Technical Analysis for FLGT - Fulgent Genetics, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Multiple of Ten Bullish | Other | 0.00% | |
| 20 DMA Resistance | Bearish | 2.14% | |
| Multiple of Ten Bearish | Other | 2.14% | |
| Down 3 Days in a Row | Weakness | 2.14% | |
| Down 4 Days in a Row | Weakness | 2.14% | |
| Fell Below 20 DMA | Bearish | -0.30% | |
| Multiple of Ten Bullish | Other | -0.30% | |
| Down 3 Days in a Row | Weakness | -0.30% | |
| 20 DMA Support | Bullish | -1.57% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 4 hours ago |
| Up 2% | about 4 hours ago |
| 60 Minute Opening Range Breakout | about 4 hours ago |
| Possible NR7 | about 6 hours ago |
| Possible Inside Day | about 6 hours ago |
Get a Trading Assistant
- Earnings date: 08/02/2024
Fulgent Genetics, Inc. Description
Fulgent Genetics, Inc. is a technology company. The Company offers genetic testing to provide physicians with clinically actionable diagnostic information to improve quality of patient care. The Company has developed a technology platform that integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory processes. As of December 31, 2015, the Company's test menu includes approximately 18,000 single-gene tests and over 200 pre-established, multi-gene, disease-specific panels that collectively test for approximately 7,500 genetic conditions, including various cancers, cardiovascular diseases and neurological disorders. The Company's gene probes are specifically engineered to generate genetic data that is optimized for its software, which enables to rapidly incorporate new genes into its test menu, develop new panels of disease-specific tests and customize tests for its customers.
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Medicine Biotechnology Cancer Genetics Cardiovascular Disease Medical Genetics Medical Test Neurological Disorders Vascular Disease Molecular Diagnostics Algorithms Applied Genetics Urological Disorders Genetic Testing Qiagen
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 44.09 |
| 52 Week Low | 18.91 |
| Average Volume | 165,534 |
| 200-Day Moving Average | 24.36 |
| 50-Day Moving Average | 20.81 |
| 20-Day Moving Average | 20.16 |
| 10-Day Moving Average | 20.08 |
| Average True Range | 0.62 |
| RSI (14) | 45.65 |
| ADX | 12.96 |
| +DI | 17.73 |
| -DI | 25.38 |
| Chandelier Exit (Long, 3 ATRs) | 19.80 |
| Chandelier Exit (Short, 3 ATRs) | 20.76 |
| Upper Bollinger Bands | 21.19 |
| Lower Bollinger Band | 19.12 |
| Percent B (%b) | 0.44 |
| BandWidth | 10.27 |
| MACD Line | -0.27 |
| MACD Signal Line | -0.31 |
| MACD Histogram | 0.0409 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 21.06 | ||||
| Resistance 3 (R3) | 21.01 | 20.61 | 20.89 | ||
| Resistance 2 (R2) | 20.61 | 20.35 | 20.64 | 20.83 | |
| Resistance 1 (R1) | 20.33 | 20.19 | 20.47 | 20.38 | 20.78 |
| Pivot Point | 19.93 | 19.93 | 20.01 | 19.96 | 19.93 |
| Support 1 (S1) | 19.65 | 19.67 | 19.79 | 19.70 | 19.30 |
| Support 2 (S2) | 19.25 | 19.51 | 19.28 | 19.25 | |
| Support 3 (S3) | 18.97 | 19.25 | 19.19 | ||
| Support 4 (S4) | 19.02 |
